ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0181

Integrated Multidisciplinary Lupus Social Work Program to Manage Social Determinants of Health in SLE and Lupus Nephritis – Preliminary Results

Kimberly DeQuattro1, Stephanie DeVaughn2, Andrew Kanoff3 and Abdallah Geara1, 1University of Pennsylvania, Philadelphia, PA, 2Uniersity of Pennsylvania, Pennsylvania, 3University of Pennsylvania, Philadelphia, PA, Philadelphia, PA

Meeting: ACR Convergence 2024

Keywords: Access to care, Disparities, Lupus nephritis, Social support, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Healthcare Disparities in Rheumatology Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Minoritized individuals with systemic lupus erythematosus (SLE) experience social determinants of health (SDOH) challenges that affect access to care and increase the risk for poorer outcomes in SLE1. Medical teams lack expertise, time, and resources to effectively address SDOH. After a pilot phase identified high volume and complexity of SDOH needs in the SLE patient population, we implemented an integrated multidisciplinary rheumatology/nephrology Lupus Social Work Program (LSWP) to manage SDOH for participants with SLE and lupus nephritis (LN).

Methods: In the pilot phase (abstract 1856027), volunteer community navigators identified frequent and complex financial and social needs for 28 participants with SLE. In response to this identified need, we developed an integrated multidisciplinary LSWP to manage SDOH in outpatient and inpatient settings in the rheumatology and nephrology divisions at an academic center. Between January and June of 2024, clinicians referred participants with SLE to a licensed social worker prioritized by high social need, disease activity, and disease severity, including LN. Referrals from clinicians through the electronic medical record (EMR) system included a trackable data element that then populated a LWSP dashboard. The lupus social worker, whose caseload was exclusive to SLE, connected with patients via text, call, EMR messaging, and in person meetings. The social worker documented assessments in the EMR and managed SDOH by providing resources. Cases were discussed in weekly meetings with the social worker, nephrologists, rheumatologists, and administrative personnel (Figure 1). Using the Children’s Hospital of Philadelphia Leading Improvement Framework, the early primary aim was to develop a workflow to increase referrals to the LSWP to 10 referrals/month for 4.5 months (1/2024-6/2024), independent of participant ancestry, insurance status, language, or beliefs. For each patient, the type of SDOH and subsequent interventions were recorded.

Results: There were 85 referrals in 18 weeks, or 19/month, exceeding the aim of 10/month (Figure 2). There were 177 LSWP encounters with documented SDOH averaging 2 encounters/referral. Most referrals were for young women (89%, 76/85) who self-identified as African American (78%, 66/85) (Table). Thirty nine percent (33/85) of participants had LN, over half (55%, 18/33) of whom had high social needs. Most frequent SDOH needs were health system navigation (20) and cost concerns (18). The top 2 interventions were social services support (51) and direct financial support (28). Twenty two percent of patients (19/85) were not reached.

Conclusion: The integrated multidisciplinary Lupus Social Work Program generated 85 referrals in the first 4.5 months, exceeding the initial aim. No answer to the initial outreach was frequent, suggesting repeated multimodal efforts are needed for a subset. For people with SLE at high risk for poor outcomes, an integrated lupus social work expert can manage a high volume of complex SDOH that may be under-addressed by clinical teams.

1Aguirre J Rheumatol 2023 PMID 37321640.

We acknowledge Michele Taylor for her contributions to this abstract.

Supporting image 1

Figure 1. Bidirectional referral process with loop closure among participants with SLE, multidisciplinary clinician teams, and integrated lupus social worker to address social determinants of health (SDOH).

Supporting image 2

Figure 2. Run chart depicting weekly referrals to Lupus Social Work Program (n=85, mean=19/month).

Supporting image 3

Table. Demographics, social determinants of health, and interventions for 85 individuals referred to the Lupus Social Work Program.


Disclosures: K. DeQuattro: None; S. DeVaughn: None; A. Kanoff: None; A. Geara: Amgen, 1.

To cite this abstract in AMA style:

DeQuattro K, DeVaughn S, Kanoff A, Geara A. Integrated Multidisciplinary Lupus Social Work Program to Manage Social Determinants of Health in SLE and Lupus Nephritis – Preliminary Results [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/integrated-multidisciplinary-lupus-social-work-program-to-manage-social-determinants-of-health-in-sle-and-lupus-nephritis-preliminary-results/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/integrated-multidisciplinary-lupus-social-work-program-to-manage-social-determinants-of-health-in-sle-and-lupus-nephritis-preliminary-results/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology